跳至主要内容
临床试验/NCT00472940
NCT00472940已完成不适用

Prevalence of Hypogonadism in Male Cancer Patients

Baylor College of Medicine1 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2006年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
135
试验地点
1

研究概览

简要总结

Cancer and its complications are common problems. In most cases, this condition has a profound impact on survival and quality of life (QoL). Fatigue, sexual dysfunction, decreased sexual drive, depression and poor appetite are commonly seen in these patients. However, these symptoms also are seen in men with other conditions including those with low testosterone levels.

The objective of this study is to determine the number of male patients with cancer that have low testosterone levels and to establish the relationship between testosterone levels and the symptoms that these patients experience.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male subjects ≥ 18 years of age with histological diagnosis of cancer for cancer group.
  • Provide written informed consent prior to screening.
  • Histological diagnosis of cancer other than non-melanoma skin cancer for the two cancer groups.

排除标准

  • Concomitant use of GH, Megestrol, Marinol, or any other anabolic agent, appetite stimulant (including corticosteroids other than dexamethasone at the time of IV chemotherapy administrations), tube feedings, or parenteral nutrition during the 3 months prior to entering the study.
  • Participation in a clinical trial with investigational agents within 1 month of enrollment.
  • Prior or current use of other medications that interfere with gonadal axis (androgens, estrogens, anti-androgens, etc).

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marco Marcelli

Professor, Medicine-Endocrinology

Baylor College of Medicine

研究点 (1)

Loading locations...

相似试验